文献速递乳腺CTMR

对比增强锥形束乳腺CT与乳腺MRI背景实质强化水平的比较

Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
PubMed 文献 · Eur Radiol · 2022-03-23

该回顾性研究纳入2017年1月至2021年4月同时行对比增强锥形束乳腺CT(CE-CBBCT)和MRI的221例患者,由5名专家独立评估背景实质强化(BPE)水平。CE-CBBCT与MRI的BPE评估呈高度一致(加权kappa=0.690),两者阅片者间信度均良好(ICC分别为0.712和0.757)。CE-CBBCT的BPE水平低于MRI(p<0.001),且与月经状态、乳腺密度及既往治疗乳腺癌相关;作者建议月经周期第2周为CE-CBBCT的最佳检查时机。

要点

  • CE-CBBCT与MRI的BPE评估呈高度一致(加权kappa=0.690),阅片者间信度良好(ICC分别为0.712和0.757)。
  • 基于多数报告,CE-CBBCT的BPE水平低于MRI(p<0.001)。
  • CE-CBBCT的BPE水平与月经状态(OR=0.125)、乳腺密度(OR=2.308)及既往治疗乳腺癌(OR=0.052)显著相关(均p<0.05)。

核心结论

  • CE-CBBCT与MRI在BPE评估上呈高度一致且阅片者间信度相当,提示可用相应BI-RADS词典描述CE-CBBCT的BPE水平;作者建议月经周期第2周为CE-CBBCT的最佳检查时机。

研究设计与样本

  • 回顾性研究,纳入2017年1月至2021年4月同时行CE-CBBCT和MRI的221例患者,由5名专家以随机方式独立评估BPE水平,洗脱期4周。

关键影像表现/征象

  • CE-CBBCT与MRI的BPE评估呈高度一致(加权kappa=0.690)。
  • CE-CBBCT的阅片者间信度良好(ICC=0.712),MRI的阅片者间信度良好(ICC=0.757)。
  • 基于多数报告,CE-CBBCT的BPE水平低于MRI(p<0.001)。

诊断标准与关键数值

  • CE-CBBCT与MRI的BPE评估一致性加权kappa=0.690。
  • CE-CBBCT的BPE评估阅片者间信度ICC=0.712。
  • MRI的BPE评估阅片者间信度ICC=0.757。

临床应用与阅片要点

  • CE-CBBCT的BPE评估与MRI呈高度一致,可用相应BI-RADS词典描述CE-CBBCT的BPE水平。
  • CE-CBBCT的BPE水平低于MRI(p<0.001),阅片时需注意两者差异。
  • CE-CBBCT的BPE水平与月经状态(OR=0.125)、乳腺密度(OR=2.308)及既往治疗乳腺癌(OR=0.052)显著相关(均p<0.05)。
  • 绝经前患者的BPE水平与月经周期相关,月经周期第2周BPE水平较低(OR=0.246)。
  • 作者建议月经周期第2周为CE-CBBCT的最佳检查时机。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the background parenchymal enhancement (BPE) levels on contrast-enhanced cone-beam breast CT (CE-CBBCT) and MRI, evaluate inter-reader reliability, and analyze the relationship between clinical factors and BPE level on CE-CBBCT.

METHODS: In this retrospective study, patients who underwent both CE-CBBCT and MRI were analyzed. BPE levels on CE-CBBCT and MRI were assessed by five specialists independently in random fashion, with a wash-out period of 4 weeks. Weighted kappa was used to analyze the agreement between CE-CBBCT and MRI, and intraclass correlation coefficient (ICC) was used to evaluate the inter-reader reliability for each modality. The association between BPE level on CE-CBBCT and clinical factors was evaluated by univariate and multivariate logistic regression.

RESULTS: A total of 221 patients from January 2017 to April 2021 were enrolled. CE-CBBCT showed substantial agreement (weighted kappa = 0.690) with MRI for BPE evaluation, with good degree of inter-reader reliability on both CE-CBBCT (ICC = 0.712) and MRI (ICC = 0.757). Based on majority reports, BPE levels on CE-CBBCT were lower than MRI (p < 0.001). BPE level on CE-CBBCT was significantly associated with menstrual status (odds ratio, OR = 0.125), breast density (OR = 2.308), and previously treated breast cancer (OR = 0.052) (all p < 0.05). BPE level for premenopausal patients was associated with menstrual cycle, with lower BPE level for the 2nd week of menstrual cycle (OR = 0.246).

CONCLUSIONS: CE-CBBCT showed substantial agreement and comparable inter-reader reliability with MRI for BPE evaluation, indicating that the corresponding BI-RADS lexicons could be used to describe BPE level on CE-CBBCT. The 2nd week of menstrual cycle timing is suggested as the optimal examination period for CE-CBBCT.

KEY POINTS: • CE-CBBCT showed substantial agreement and comparable inter-reader reliability with MRI for BPE evaluation. • Menstrual status, breast density, and previously treated breast cancer were associated with the BPE level on CE-CBBCT images. • The 2ndweek of the menstrual cycle is suggested as the optimal examination period for CE-CBBCT.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ma, Liu, Zhang, et al. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI. Eur Radiol. 2022. PMID: 35320411. doi:10.1007/s00330-022-08699-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。